Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-1994 | 10-1993 | 07-1993 | 04-1993 | 01-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,580 | 3,714 | 3,258 | 3,126 | 2,793 |
| TOTAL | $3,580 | $3,714 | $3,258 | $3,126 | $2,793 |
| Non-Current Assets | |||||
| PPE Net | 10,495 | 10,098 | 8,931 | 8,629 | 8,598 |
| Other Non-Current Assets | 4,428 | 4,417 | 4,315 | 4,429 | 4,472 |
| TOTAL | $14,923 | $14,515 | $13,246 | $13,058 | $13,070 |
| Total Assets | $18,503 | $18,229 | $16,504 | $16,184 | $15,863 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,979 | 8,117 | 7,965 | 6,248 | 3,944 |
| Accrued Expenses | 3,830 | 3,920 | 3,353 | 3,166 | 2,776 |
| TOTAL | $31,934 | $27,710 | $17,383 | $11,607 | $8,830 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 783 | 813 | 840 | 831 | 821 |
| TOTAL | $2,300 | $2,486 | $2,471 | $2,481 | $2,534 |
| Total Liabilities | $34,234 | $30,196 | $19,854 | $14,088 | $11,364 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -7,520 | -7,608 | -7,656 | -7,200 | -171 |
| TOTAL | $16,188 | $16,100 | $16,052 | $16,508 | $16,507 |
| Total Liabilities And Equity | $50,422 | $46,296 | $35,906 | $30,596 | $27,871 |